每经AI快讯，安利股份（SZ 300218，收盘价：19.84元）发布公告称，2025年9月17日13:00-15:00，安 利股份接受开源证券等投资者调研，公司董事会秘书刘松霞等人参与接待，并回答了投资者提出的问 题。 每经头条（nbdtoutiao）——海拔4306米现"秦始皇密令"，获官方"身份认定"！古文字学家刘钊：秦人 寻仙采药足迹确至青藏高原 2024年1至12月份，安利股份的营业收入构成为：人造革合成革占比98.35%，其他业务占比1.65%。 （记者 曾健辉） 截至发稿，安利股份市值为43亿元。 ...

Company Overview - Amway Co., Ltd. (SZ 300218) announced that on September 5, 2025, it will accept investor research from Guohai Securities and others, with participation from the company's board secretary and deputy general manager, Liu Songxia [1] - As of the report, Amway's market capitalization stands at 4.7 billion yuan [1] Financial Performance - For the year 2024, Amway's revenue composition is as follows: synthetic leather accounts for 98.35% and other businesses account for 1.65% [1]

Group 1 - The company reported a revenue of 1.215 billion yuan for the first half of 2025, representing a year-on-year increase of 23.71% [1] - The net profit attributable to shareholders reached 134 million yuan, a significant year-on-year growth of 166.61%, indicating improved operational quality [1] - The optical-grade PMMA/MS materials segment achieved a revenue of 872 million yuan, with a year-on-year growth of 35.21% and a gross margin of 18.69%, up 7.07% year-on-year, serving as the core driver of performance growth [1] Group 2 - The synthetic leather segment generated a revenue of 326 million yuan, with a gross margin increase to 17.55%, benefiting from product structure optimization and cost control [2] - The hazardous waste treatment business reported revenue of 17.78 million yuan, a year-on-year increase of 82.9%, becoming a new profit growth point [2] - Export revenue reached 152 million yuan, a year-on-year increase of 74.1%, with significant growth in domestic markets, particularly in Central, North, and Northeast China [2] Group 3 - R&D expenses amounted to 45.1 million yuan, a year-on-year increase of 38.7%, focusing on optimizing optical material performance and improving eco-friendly synthetic leather processes [3] - The company has obtained numerous national invention patents and is involved in various national and provincial research projects, strengthening its technological barriers [3] - Future strategies include accelerating PMMA/MS capacity release, enhancing synthetic leather quality, expanding hazardous waste business, and increasing R&D investment to improve core competitiveness [3]

Group 1 - Company Amway Co., Ltd. (SZ 300218) announced on August 25 that its seventh board meeting was held on August 22, 2025, to discuss the proposal for the second extraordinary shareholders' meeting of 2025 [1] - For the year 2024, Amway's revenue composition is as follows: synthetic leather accounts for 98.35%, while other businesses account for 1.65% [1] - As of the report date, Amway's market capitalization is 5.2 billion yuan [1]

Core Viewpoint - Amway Co., Ltd. has officially launched the remaining two dry production lines in Vietnam, marking a significant expansion in its production capacity [2]. Group 1: Company Developments - Amway Vietnam has completed the installation, debugging, and trial production of the remaining two dry production lines, which are now in full operation [2]. - For the fiscal year 2024, Amway Co., Ltd. projects that its revenue composition will be 98.35% from synthetic leather and 1.65% from other businesses [2].

Group 1 - Amway Co., Ltd. (SZ 300218, closing price: 23.74 CNY) announced that it will accept investor research on August 8, 2025, from 16:00 to 17:30, with participation from the company's board secretary and deputy general manager Liu Songxia and securities affairs representative Chen Liting [2] - For the year 2024, Amway's revenue composition is as follows: synthetic leather accounts for 98.35%, while other businesses account for 1.65% [2]

Group 1 - Amway Co., Ltd. (SZ 300218, closing price: 20.96 yuan) announced that it will accept investor research on August 7, 2025, from 10:00 to 11:30, with participation from key executives including Chairman and General Manager Yao Heping, Board Secretary and Deputy General Manager Liu Songxia, Securities Affairs Representative Chen Liting, and Securities Director Wang Rui [2] - For the year 2024, Amway's revenue composition is as follows: synthetic leather accounts for 98.35%, while other businesses account for 1.65% [2]